1. LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials. (4th December 2021) Authors: Le Gars, Mathieu; Sadoff, Jerald; Jongeneelen, Mandy; Heerwegh, Dirk; Shukarev, Georgi; Truyers, Carla; de Groot, Anne Marit; Scheper, Gert; Hendriks, Jenny; Brandenburg, Boerries; Struyf, Frank; Van Hoof, Johan; Douoguih, Macaya; Schuitemaker, Hanneke Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials. (4th December 2021) Authors: Le Gars, Mathieu; Sadoff, Jerald; Jongeneelen, Mandy; Heerwegh, Dirk; Shukarev, Georgi; Truyers, Carla; de Groot, Anne Marit; Scheper, Gert; Hendriks, Jenny; Brandenburg, Boerries; Struyf, Frank; Van Hoof, Johan; Douoguih, Macaya; Schuitemaker, Hanneke Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials. Issue 32 (30th July 2022) Authors: Sadoff, Jerald; Le Gars, Mathieu; Brandenburg, Boerries; Cárdenas, Vicky; Shukarev, Georgi; Vaissiere, Nathalie; Heerwegh, Dirk; Truyers, Carla; de Groot, Anne Marit; Jongeneelen, Mandy; Kaszas, Krisztian; Tolboom, Jeroen; Scheper, Gert; Hendriks, Jenny; Ruiz-Guiñazú, Javier; Struyf, Frank; Van H... Journal: Vaccine Issue: Volume 40:Issue 32(2022) Page Start: 4403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age. Issue 5 (30th November 2022) Authors: Ong-Lim, Anna Lisa; Shukarev, Georgi; Trinidad-Aseron, Mitzi; Caparas-Yu, Delia; Greijer, Astrid; Duchene, Michel; Scheper, Gert; van Paassen, Vitalija; Le Gars, Mathieu; Cahill, Conor P.; Schuitemaker, Hanneke; Douoguih, Macaya; Jacquet, Jeanne-Marie Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease. Issue 2 (24th April 2017) Authors: Khan, Selina; Oosterhuis, Koen; Wunderlich, Kerstin; Bunnik, Evelien M.; Bhaggoe, Melissa; Boedhoe, Satish; Karia, Santusha; Steenbergen, Renske D.M.; Bosch, Leontien; Serroyen, Jan; Janssen, Sarah; Schuitemaker, Hanneke; Vellinga, Jort; Scheper, Gert; Zahn, Roland; Custers, Jerome Journal: International journal of cancer Issue: Volume 141:Issue 2(2017:Jul. 15) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses. Issue 30 (16th July 2018) Authors: Vujadinovic, Marija; Khan, Selina; Oosterhuis, Koen; Uil, Taco G.; Wunderlich, Kerstin; Damman, Sarra; Boedhoe, Satish; Verwilligen, Annemiek; Knibbe, Jonathan; Serroyen, Jan; Schuitemaker, Hanneke; Zahn, Roland; Scheper, Gert; Custers, Jerome; Vellinga, Jort Journal: Vaccine Issue: Volume 36:Issue 30(2018) Page Start: 4462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins. Issue 7 (1st December 2017) Authors: Çuburu, Nicolas; Khan, Selina; Thompson, Cynthia D.; Kim, Rina; Vellinga, Jort; Zahn, Roland; Lowy, Douglas R.; Scheper, Gert; Schiller, John T. Journal: International journal of cancer Issue: Volume 142:Issue 7(2018) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease. Issue 2 (24th April 2017) Authors: Khan, Selina; Oosterhuis, Koen; Wunderlich, Kerstin; Bunnik, Evelien M.; Bhaggoe, Melissa; Boedhoe, Satish; Karia, Santusha; Steenbergen, Renske D.M.; Bosch, Leontien; Serroyen, Jan; Janssen, Sarah; Schuitemaker, Hanneke; Vellinga, Jort; Scheper, Gert; Zahn, Roland; Custers, Jerome Journal: International journal of cancer Issue: Volume 141:Issue 2(2017:Jul. 15) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗